Warriors and Survivors - 287

Children Cancer Stories by Rukh Yusuf - Blog # 287

I am Rukh Yusuf, Clinical Pharmacist, also specialized in Total Parenteral Nutrition and Bone Marrow Transplant. I have worked in the Pediatric Oncology unit of a public hospital. The mission of this blog is to bring to you the real-life stories of child patients suffering from cancer. Cancer is still a difficult disease to handle and treat. However, when it strikes the children, some so young that they cannot even speak, their agony is beyond expression and words. Let us pray especially for children suffering from cancer for early and complete remission. May Allah shower His Merciful Blessings upon them. Aameen. 

The Unseen : When Patients Become Part of Your Heart

Working in a pediatric oncology facility is unlike working in many other healthcare settings. It is a place where science, hope, fear, courage, and heartbreak exist side by side. Every day, healthcare providers walk into the hospital prepared to treat diseases, manage complications, administer medications, and support families. But somewhere along the way, we begin to do something that cannot be written into a job description: they become emotionally attached to the children they care for.

In pediatric oncology, patients are not always there for a few hours or days. Some stay for weeks, months, or even longer. They return for chemotherapy cycles, recover from complications, undergo bone marrow transplantation, and navigate repeated hospital admissions. Over time, familiar faces become part of our daily lives. We learn their names, recognize their voices, remember their favorite activities, and begin to understand their personalities. We witness their fears, celebrate their smallest victories, and sometimes become part of their families' most difficult moments.

And without even realizing it, we become attached.

When Caring Becomes Personal:  Healthcare providers in pediatric oncology work in different capacities. Some administer chemotherapy, others monitor vital signs, manage infections, prepare medications, provide emotional support, or help families understand complicated treatment plans. Although our responsibilities differ, we share something fundamental: we care for children who are fighting illnesses no child should have to face.

When you see a child repeatedly, it becomes difficult to think of them as just another patient. You remember how frightened they were during their first admission, how they gradually became comfortable with the hospital environment, and how excited they were when they finally felt well enough to play again.

You celebrate when their blood counts improve, when they tolerate treatment, and when they are finally discharged. These moments remind you why your work matters.

But the same attachment that makes the happy moments meaningful also makes the difficult ones much harder.

The Weight We Carry Beyond Hospital Walls

One of the most challenging aspects is that the emotional responsibility does not always end when the duty hours are over.

I still recall almost every child I have interacted with in hospital. I remember their faces, their struggles, and the moments we shared. Some memories bring a smile; others remain painful to revisit.

You may be physically at home, but a part of your mind is still in the hospital.

When we become emotionally invested in these young warriors, switching off is not always easy. A child's worsening condition can follow you home. An unexpected complication can occupy your thoughts throughout the evening. And when a patient you have cared for over a long period deteriorates, the emotional impact can be difficult to explain to someone who has never experienced this environment.

We are trained to remain professional, make evidence based decisions, and provide the best possible care. However, professional training does not make us immune to human emotions.

The More Sensitive You Are, the More You May Hurt: 

There is a particular vulnerability in caring deeply. The more sensitive you are to another person's suffering, the more intensely you may experience it yourself.

This sensitivity can be both a strength and a burden. It helps us recognize distress, communicate compassionately, understand families' fears, and treat children with dignity. Yet it can also leave us emotionally exhausted.

We may struggle when treatment does not work as hoped. We may feel helpless when a child continues to suffer despite every effort. And when a child we have grown attached to dies, we may experience grief that is difficult to express in a professional environment where we are expected to continue working.

Sometimes, we move from one patient's bedside to another, carrying our emotions quietly because the next child still needs us.

There is little time to process one difficult experience before another begins.

This is the reality of caring in a setting where hope and uncertainty coexist every day.

Compassion Needs Care, Too: Healthcare providers are often praised for their strength, resilience, and ability to remain composed under pressure. But resilience should not mean becoming emotionally numb, and professionalism should not require pretending that difficult experiences do not affect us.

We need spaces where healthcare workers can talk about their experiences without feeling that vulnerability is a weakness. Peer support, supportive colleagues, reflective practices, and access to psychological support can help us process the emotional demands of our work. Healthy boundaries are equally important not because we should care less, but because we need to sustain our ability to care over time.

We cannot control every outcome. We cannot remove every child's pain or guarantee that every treatment will succeed. What we can do is provide competent, compassionate care and recognize that our own emotional well-being deserves attention, too.

We May Leave the Hospital, but the Memories Stay

Treating these angles changes you. It teaches you to appreciate small victories, to recognize courage in unexpected places, and to understand how much strength can exist in someone so young.

It also teaches you that caring deeply comes with a cost.

I still remember the children I have cared for, and I suspect I always will. Their struggles have stayed with me long after individual shifts and hospital admissions ended. When patients are sick, I still find myself worrying about them even after my duty hours.

Perhaps this is one of the most difficult truths about working for these little warriors : we can learn to manage our emotions, but we cannot always prevent ourselves from feeling them.

And perhaps we should not want to.

Because behind every clinical task, every medication, every treatment plan, and every hospital admission is a child who deserves to be treated as more than a diagnosis.

Warriors and Survivors - 286

Children Cancer Stories by Rukh Yusuf - Blog # 286

I am Rukh Yusuf, Clinical Pharmacist, also specialized in Total Parenteral Nutrition and Bone Marrow Transplant. I have worked in the Pediatric Oncology unit of a public hospital. The mission of this blog is to bring to you the real-life stories of child patients suffering from cancer. Cancer is still a difficult disease to handle and treat. However, when it strikes the children, some so young that they cannot even speak, their agony is beyond expression and words. Let us pray especially for children suffering from cancer for early and complete remission. May Allah shower His Merciful Blessings upon them. Aameen. 

Ahmar: A Four-Year-Old’s Journey from Gujrat to Lahore

Ahmar is only four years old.

He comes from Gujrat, where his family has their home, their routine, and the life they knew before cancer became part of it. Today, however, much of that routine revolves around a different place Lahore, where Ahmar comes for his treatment for acute lymphoblastic leukemia (ALL).

For a family living in another city, cancer treatment does not begin and end at the hospital door. The journey starts much earlier, when the family prepares to leave home. A trip to Lahore means arranging transportation, gathering Ahmar’s medicines and documents, making sure someone can accompany him, and preparing for the uncertainty of how long they may need to stay.

For Ahmar, it is simply another journey to the hospital.

At four years old, he cannot fully understand what leukemia means. He does not know why his blood needs to be checked so often or why medicines have become part of his daily life. He knows the hospital. He knows the doctors and nurses. He knows that there will be examinations, blood tests, medicines, and sometimes procedures that he would much rather avoid.

His diagnosis changed the ordinary rhythm of childhood.

Before cancer, a four-year-old's day is usually measured in small things when to eat, when to sleep, what toy to play with, where to go, and what game to play next. For Ahmar, treatment has added another schedule to his life. His days are now influenced by appointments, laboratory tests, treatment cycles, medicines, and follow-up visits.

ALL is a cancer of the blood and bone marrow, and its treatment is prolonged. It is not something that can be treated with one medicine or one hospital visit. Children generally go through different phases of therapy, with treatment adjusted according to their response and clinical needs. This means that Ahmar's family has to remain connected with the hospital for a long time.

And that means traveling.

Gujrat and Lahore are not next-door cities. Every trip takes time, money, energy, and planning. For Ahmar's parents, the journey is not just the distance between two cities. It is another responsibility added to an already difficult situation.

They have to think about transportation and expenses. They have to manage their work and household responsibilities. They have to make arrangements for other family members while bringing Ahmar for treatment. If he is unwell after treatment, the return journey becomes even more difficult.

There are also the things that cannot be easily measured.

A parent sitting beside a child during treatment notices every small change. Is he eating today? Does he look more tired than usual? Does he have a fever? Is he uncomfortable? Is he sleeping properly? These questions follow parents even after they leave the hospital.

For Ahmar, some days may be easier than others. There may be days when he wants to play, talk, or move around like any other four-year-old. There may also be days when treatment leaves him tired and he simply wants to rest in his parent's arms.

These ordinary moments are an important part of his story.

In the hospital, Ahmar is a patient. At home, he is a son. He is the little boy whose family worries about his medicines, his meals, his sleep, and his next appointment. His parents are not only trying to understand his illness; they are also trying to preserve some sense of normal childhood for him while treatment continues.

Sometimes that may mean distracting him during a procedure. Sometimes it may mean bringing something familiar from home. Sometimes it may simply mean sitting beside him quietly.

For the family, there is no separation between Ahmar's treatment and their everyday life anymore. The illness has become part of their planning, their travel, their expenses, and their conversations.

And then there is the journey back to Gujrat.

After a hospital visit, they leave Lahore carrying the same child they brought in, but often with new medicines, new instructions, another appointment, and another date to return. The road home may be familiar, but the circumstances are not.

This is what Ahmar's treatment looks like not one dramatic moment, but many ordinary difficult days repeated over and over.

A four-year-old making a long journey because he needs treatment.

Parents making the same journey because their son needs them.

And a family from Gujrat continuing to travel to Lahore, one hospital visit at a time, while Ahmar grows up in between his treatments.

His story is not only about leukemia. It is also about what treatment asks of a child and the family around him the travel, the waiting, the medicines, the uncertainty, and the effort to keep everyday life going.

For Ahmar, childhood is still happening.

It is just happening alongside treatment in a different way.

Note: Patient name has been changed to protect privacy. 

Warriors and Survivors - 285

Children Cancer Stories  -  Blog Post # 285

I am honored to feature a guest contribution by Asrar Qureshi, offering valuable perspectives on childhood cancer care and the importance of equitable access to treatment worldwide. In this guest blog , Asrar Qureshi brings attention to important challenges in pediatric oncology and the need for more equitable access to quality cancer care for children worldwide.

Why Should Childhood Cancer Survival Depend on Where the Child is Born? – Asrar Qureshi’s Blog Post #1319

Dear Colleagues! This is Asrar Qureshi’s Blog Post #1319 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here.

Preamble

This post is based on a World Health Organization Report.. Link at the end.

WHO’s 2026 report, Measuring survival, driving change: advancing equity through the WHO Global Initiative for Childhood Cancer, examines one of the most striking inequalities in global health: children with cancer can face dramatically different chances of survival depending on where they live. The report introduces comparable five-year survival estimates for lymphoid leukaemia across 194 Member States and links better data to stronger policy and health-system action. WHO’s global target is at least 60% childhood-cancer survival by 2030.

Childhood Cancer: Why Where a Child Lives Should Not Determine Whether They Survive

Cancer is often associated with older age. But cancer also affects children, and when it does, the consequences are devastating not only for the child but for parents, siblings and entire communities. What makes childhood cancer particularly troubling is that survival is no longer simply a question of whether effective treatments exist. In many parts of the world, children with cancer can survive if they are diagnosed early, receive appropriate treatment and have access to quality supportive care. The problem is that these conditions are not equally available everywhere.

A Child's Chances Should Not Depend on Geography

Perhaps the most disturbing feature of childhood cancer is the enormous difference in survival between countries. WHO reports that survival exceeds 80% in many high-income settings, while it remains below 30% in some low-resource countries.

Think about what this means. The disease is not necessarily fundamentally different because a child was born in one country rather than another. A child's chances of surviving cancer can be heavily influenced by the health system into which that child happens to be born. That is not simply a medical problem. It is a systems problem.

Childhood Cancer Is Different

Children are not simply small adults. Childhood cancers have distinctive biological and clinical characteristics, and their diagnosis and treatment require specialized approaches. The WHO report emphasizes the unique characteristics and epidemiology of childhood cancers as part of understanding the global survival gap. This matters because treatment requires more than making medicines available.

A medicine sitting on a shelf does not save a child. A functioning healthcare system does.

The First Challenge: Diagnosing the Disease

One of the major barriers identified by WHO is timely diagnosis. Cancer can be difficult to recognize, particularly in primary-care settings where healthcare workers may encounter relatively few childhood cancer cases. Symptoms may resemble more common childhood illnesses.

If cancer is not recognized promptly, the child may move through several healthcare providers before reaching a specialist. Every delay matters.

The Second Challenge: Access to Treatment

Diagnosis alone is not enough. Once cancer is identified, the child needs appropriate treatment. This is where differences between health systems become even more consequential.

Specialized oncology services may be concentrated in major cities. Families living in rural or remote areas may have to travel long distances. Treatment may extend over months. Parents may have to stop working. Transport and accommodation may become unaffordable. Medicines may not always be consistently available. This is why WHO's approach is broader than simply increasing the supply of cancer medicines. The objective is to strengthen the entire system that enables a child to receive appropriate care.

The Hidden Problem: Continuity of Care

Cancer treatment is rarely a single event. It is a journey.

Diagnosis is followed by treatment. Treatment requires monitoring. Complications may require urgent intervention. Patients need follow-up. And families need support throughout the process. A child who begins treatment but cannot complete it does not receive the full benefit of modern cancer care. WHO identifies barriers affecting timely diagnosis, access to treatment and continuity of care as persistent challenges.

This is a critical insight for health policymakers.

Data Can Change the Conversation

One of the most important contributions of the WHO report is its emphasis on data.

For many health problems, policymakers cannot manage what they cannot measure. Historically, reliable, comparable information about childhood-cancer outcomes has been limited in many countries.

WHO's new country-comparable five-year survival estimates for lymphoid leukaemia across 194 Member States represent an important step toward filling this gap.

Data transforms a general concern into a management problem. That is why cancer registries and surveillance systems are not administrative luxuries. They are instruments of health policy.

The Importance of Population-Based Cancer Registries

WHO highlights the critical role of high-quality population-based cancer registries in generating the data needed for evidence-informed policymaking and monitoring progress. A strong registry can help governments understand the real burden of disease. Without reliable registration, countries may underestimate the number of children affected.

Data infrastructure should be viewed as part of healthcare infrastructure. A cancer registry may not look as visible as a new hospital. But over time, it can help determine where hospitals, specialists, medicines and other resources are most urgently required.

The CureAll Framework

WHO's Global Initiative for Childhood Cancer uses the CureAll framework as a structured approach for strengthening childhood-cancer programmes. The framework is designed to support national planning, implementation, monitoring and evaluation and to help countries move toward better survival and reduced suffering.

Its significance lies in recognizing that no single intervention will close the survival gap. A country needs coordinated action. It needs political commitment. It needs appropriate treatment capacity. It needs systems for measuring progress. It needs partnerships. And it needs sustained investment. This is an important lesson for health-sector leaders.

The Pharmaceutical Industry Has a Role

The WHO report also has implications for the pharmaceutical industry. Pharmaceutical companies are important stakeholders in the childhood-cancer ecosystem, particularly in developing and supplying medicines, supporting research and contributing to healthcare capacity.

But the industry's contribution should not be viewed solely through the traditional lens of product supply. The larger challenge is ensuring that effective therapies can actually reach children who need them.

There is also an opportunity for greater collaboration in research. Clinical research in childhood cancer faces particular challenges because patient populations are relatively small and specialized expertise is required.

The 60% Target Is More Than a Number

WHO's Global Initiative for Childhood Cancer has established a global target of achieving at least 60% survival among children with cancer by 2030, while reducing inequities in outcomes.

Targets matter because they create accountability. But the real importance of the 60% target is not the number itself. It represents a commitment to narrowing the enormous gap between children who currently have very different chances of survival.

For countries with low survival rates, reaching the target will require more than incremental improvements. It will require coordinated transformation.

From Measuring Survival to Saving Lives

The title of the WHO report contains two powerful ideas: Measuring survival and driving change. The sequence matters.

First, measure, then understand the gaps, then identify the causes, then intervene, then measure again. This is the essence of evidence-based management. The lesson extends beyond childhood cancer.

The Real Measure of a Health System

A healthcare system should ultimately be judged not only by the sophistication of its hospitals or the availability of its technology. It should also be judged by whether a child in a disadvantaged community has a meaningful opportunity to receive timely, quality care.

That is the heart of the WHO report. Childhood cancer exposes an uncomfortable reality: Medical progress alone does not guarantee health progress.

A system in which data informs policy, primary care recognizes warning signs, referral pathways function, treatment is available and continuous, families are supported, and progress is measured transparently. Every child with cancer deserves that system.

Concluded.

Disclaimers: Pictures in these blogs are taken from free resources at Pexels, Pixabay, Unsplash, and Google. Credit is given where available. If a copyright claim is lodged, we shall remove the picture with appropriate regrets.

For most blogs, I research from several sources which are open to public. Their links are mentioned under references. There is no intent to infringe upon anyone’s copyrights. If, any claim is lodged, it will be acknowledged and duly recognized immediately.

Reference:

https://www.who.int/publications/i/item/9789240122772

Warriors and Survivors - 284

 Children Cancer Stories by Rukh Yusuf - Blog # 284

I am Rukh Yusuf, Clinical Pharmacist, also specialized in Total Parenteral Nutrition and Bone Marrow Transplant. I have worked in the Pediatric Oncology unit of a public hospital. The mission of this blog is to bring to you the real-life stories of child patients suffering from cancer. Cancer is still a difficult disease to handle and treat. However, when it strikes the children, some so young that they cannot even speak, their agony is beyond expression and words. Let us pray especially for children suffering from cancer for early and complete remission. May Allah shower His Merciful Blessings upon them. Aameen. 

Going Gold in September: Raising Awareness for Childhood Cancer

September is recognized as Childhood Cancer Awareness Month, a time to acknowledge children and adolescents living with cancer, remember those who have lost their lives, celebrate survivors, and draw attention to the need for better diagnosis, treatment, research, and supportive care. The international symbol of this movement is the gold ribbon.

The choice of gold is meaningful, the gold ribbon represents all childhood and adolescent cancers. Gold was selected because it is a precious metal, reflecting the value and preciousness of children. 

The story behind the gold ribbon

The history of the gold ribbon goes back to the experiences of parents of children with cancer. In 1997, Gigi Thorsen, a board member of the Candlelighters Childhood Cancer Foundation, worked with other parents affected by childhood cancer to establish a universal symbol for childhood cancer awareness. The first gold ribbon products were produced as lapel pins in 1997, and the symbol gradually spread beyond the United States. 

Historical records from the organization describe how Thorsen was inspired by her daughter Kelsey, who died from leukemia in 1996. The first gold cloth ribbons appeared in September 1997, followed by gold ribbon pins in 1998. The campaign grew through parent networks and early internet support groups. 

Today, the gold ribbon represents much more than awareness. It represents children undergoing treatment, survivors living beyond cancer, parents and siblings, healthcare professionals, researchers, advocates, and families remembering children who are no longer with them.

The global burden of childhood cancer

Childhood cancer is sometimes described as rare, but its global impact is substantial. The World Health Organization estimates that approximately 400,000 children and adolescents aged up to 19 years develop cancer each year. Common childhood cancers include leukemia, brain tumors, lymphomas, neuroblastoma, Wilms tumor, retinoblastoma, and other solid tumors. 

More recent estimates from the International Agency for Research on Cancer (IARC) indicate that more than 275,000 children and young people aged 0 to 19 were diagnosed with cancer in 2024, with more than 100,000 deaths. IARC also cautions that the actual burden may be considerably higher because childhood cancers can be missed or under recorded in countries where diagnostic services and cancer registries are limited. 

Perhaps the most important message is that childhood cancer outcomes are not determined only by the biology of the disease. Where a child is born can strongly influence whether that child survives. In high-income countries, more than 80% of children with cancer can now be cured. In many low and middle income countries, however, fewer than 30% survive. 

This difference reflects inequalities in early diagnosis, pathology and diagnostic services, availability of medicines, trained healthcare professionals, treatment infrastructure, supportive care, treatment abandonment, and the ability of families to reach and remain in care. Nearly 94% of childhood cancer deaths are estimated to occur in Africa, Asia, South America, and the Caribbean. 

Childhood cancer in Pakistan

For Pakistan, the issue is particularly important. Available estimates suggest that approximately 8,000 to 10,000 children are diagnosed with cancer each year. 

These numbers, however, should be interpreted carefully. Pakistan, like many countries, continues to face challenges in comprehensive cancer registration and accurate population level data. Consequently, the reported number of cases may not capture the entire burden.

The challenges extend beyond diagnosis. Children and families may face delays in reaching specialized pediatric oncology centers, limited access to essential medicines and diagnostic facilities, financial pressures, and difficulties maintaining treatment over a prolonged period. Awareness among families and healthcare providers is therefore an important component of improving outcomes. Recognizing concerning symptoms and referring children promptly can help reduce diagnostic delays. 

There are also reasons for optimism. Pakistan has been included in international efforts to strengthen childhood cancer care. WHO reported that Pakistan was selected in 2024 as part of the second cohort of countries enrolled in the Global Platform for Access to Childhood Cancer Medicines, an initiative designed to improve access to quality-assured cancer medicines. 

Why does awareness matter?

Awareness is about creating a better understanding of childhood cancer throughout the year.

For parents and communities, awareness can encourage timely medical attention when a child's symptoms are persistent or unusual. For healthcare professionals, it reinforces the importance of considering cancer in appropriate clinical situations and making timely referrals. For health systems, awareness can generate public support for pediatric oncology services, cancer registries, essential medicines, psychosocial support, survivorship programs, and research.

Awareness also helps challenge misconceptions. Childhood cancer is not a punishment, and families should not be blamed for their child's illness. 

Most importantly, awareness can help shift the conversation from “How many children have cancer?” to “What can we do so that every child has a chance to survive?”

The WHO Global Initiative for Childhood Cancer has set a goal of achieving at least 60% survival globally by 2030 while reducing suffering among children with cancer. 

This September, the gold ribbon reminds us that childhood cancer is a global health issue but also a global opportunity for action. Every diagnosis represents a child with dreams, a family with hopes, and a future worth protecting. Going gold means remembering those children, supporting those in treatment, celebrating survivors, strengthening pediatric oncology systems, and ensuring that geography does not determine a child's chance of survival.

This September, let us turn the world gold, not only to raise awareness, but to turn awareness into earlier diagnosis, equitable treatment, stronger research, and better futures for children everywhere.

Warriors and Survivors - 283

Children Cancer Stories by Rukh Yusuf - Blog # 283

I am Rukh Yusuf, Clinical Pharmacist, also specialized in Total Parenteral Nutrition and Bone Marrow Transplant. I have worked in the Pediatric Oncology unit of a public hospital. The mission of this blog is to bring to you the real-life stories of child patients suffering from cancer. Cancer is still a difficult disease to handle and treat. However, when it strikes the children, some so young that they cannot even speak, their agony is beyond expression and words. Let us pray especially for children suffering from cancer for early and complete remission. May Allah shower His Merciful Blessings upon them. Aameen. 

When the World Comes Together for a Child with Cancer

A child with cancer does not think about whether the hospital is in a high-income country or a low- or middle-income country. A child does not know whether the treatment is being given in a large academic medical center or a small hospital far from home. A child only knows that they are sick and that they need someone to help them get better.

But where a child is born can make a profound difference in the care they receive.

This is one of the reasons the work of the International Society of Paediatric Oncology (SIOP) matters. SIOP is a global multidisciplinary society dedicated entirely to childhood and adolescent cancer. Its purpose is not limited to discovering new medicines or discussing the latest research. Its mission is to improve the lives of children and adolescents with cancer through collaboration, education, training, research, and advocacy.

Every year, SIOP brings together people who may otherwise work thousands of miles apart pediatric oncologists, nurses, pharmacists, surgeons, radiation oncologists, researchers, psychologists, scientists, allied health professionals, advocates, trainees, and many others. The annual congress creates a space where these different experiences can meet.

Attending SIOP 2026 in San Antonio, and being here has a meaning beyond attending another professional conference. The 58th SIOP Congress is bringing together the global pediatric oncology community from September 14–18, with discussions ranging from basic and translational research to clinical care, supportive care, survivorship, precision medicine, and global oncology.

What makes such a gathering important is the opportunity to learn from one another.

A researcher may present findings that could eventually change treatment. A physician from another country may share a practical solution developed because resources are limited. A nurse may describe how families cope with treatment. A pharmacist may talk about medication access and safe use. Someone working in a resource limited hospital may explain a challenge that is not visible in a well-resourced health system.

These conversations matter because pediatric cancer is not only a scientific problem. It is also a problem of access.

Nearly 90% of children with cancer live in low- and middle-income countries, according to St. Jude Global. Many children in these settings face difficulties with diagnosis, access to medicines, trained healthcare professionals, treatment infrastructure, and continuity of care. St. Jude estimates that around 400,000 children develop cancer each year, yet only about half are ever diagnosed.

This is where global collaboration becomes especially important.

St. Jude Global was established to help address these disparities. Its approach is not simply to provide treatment from one hospital to another country. It focuses on building capacity, training healthcare professionals, strengthening health systems, supporting patient-centered care, developing regional networks, and advancing research.

There is an important idea behind this approach: sustainable improvement has to happen within the healthcare systems where children actually live.

A hospital needs trained people. It needs reliable diagnostic services. It needs medicines. It needs systems that allow children to complete treatment. Families need support. Healthcare workers need education and opportunities to learn. Researchers need data and collaborations. None of these challenges can be solved by one person or one institution working alone.

St. Jude Global's work with international partners reflects this understanding. Its collaboration with the World Health Organization contributed to the Global Initiative for Childhood Cancer, which aims to improve outcomes through coordinated efforts across countries and health systems. The initiative's CureAll approach seeks at least a 60% survival rate for children with six common childhood cancers by 2030.

Behind these numbers are children.

Children like the ones we meet in pediatric oncology clinics. Children who travel long distances for treatment. Children whose parents leave work to stay beside them. Children who may spend months or years moving between home and hospital.

For families, a cancer diagnosis is never simply a diagnosis. It affects transportation, finances, education, employment, siblings, parents, and everyday life. In many places, even reaching a hospital that can provide appropriate treatment can be a challenge.

This is why conferences like SIOP are important. They create opportunities for people from different parts of the world to sit at the same table and think about the same child.

The goal is not for every country to have exactly the same healthcare system. The goal is to make sure that children receive the best possible care within their circumstances, and that knowledge and experience are shared rather than remaining within the walls of one institution or one country.

For me, attending SIOP is also a reminder of why pediatric oncology requires teamwork. As healthcare professionals, we may have different responsibilities, different training, and different perspectives, but ultimately the patient brings us together.

A physician may diagnose the cancer. A pharmacist may help make sure the medicines are appropriate and safely used. A nurse may spend hours at the bedside. A laboratory scientist may provide information essential to diagnosis and treatment. A researcher may identify a new way of understanding the disease. A psychologist may help a child and family cope with what treatment brings into their lives.

Each role is different. The child is at the center of all of them.

That is perhaps the most meaningful part of being at SIOP 2026: seeing people from around the world come together not simply to talk about cancer, but to share knowledge, experience, challenges, and solutions for children who may never know the names of the people working to improve their care.

The work is complex, and progress takes time.

But every connection made, every lesson shared, every healthcare worker trained, every system strengthened, and every research question pursued can become part of a much larger effort.

Because ultimately, global pediatric oncology is about something very simple.

A child should have a chance to grow up.

And wherever that child happens to be born, that chance should matter.

Warriors and Survivors - 282

Children Cancer Stories by Rukh Yusuf - Blog # 282

I am Rukh Yusuf, Clinical Pharmacist, also specialized in Total Parenteral Nutrition and Bone Marrow Transplant. I have worked in the Pediatric Oncology unit of a public hospital. The mission of this blog is to bring to you the real-life stories of child patients suffering from cancer. Cancer is still a difficult disease to handle and treat. However, when it strikes the children, some so young that they cannot even speak, their agony is beyond expression and words. Let us pray especially for children suffering from cancer for early and complete remission. May Allah shower His Merciful Blessings upon them. Aameen. 

Mehak is five years old.

She should be running around chasing her cat without thinking about hospitals. But for Mehak, the hospital has become a familiar part of childhood. She was diagnosed with thalassemia major when she was only two years old.

Since then, blood transfusions have become a regular part of her life. In the beginning, she needed a transfusion about once a month. As time passed, her need increased. Now, there are times when she needs blood twice in the same month.

For a five-year-old, this is a lot.

Mehak may not fully understand what blood is, why she needs it, or why she has to sit quietly in a hospital while someone gives her blood through a small needle. She simply knows that there are hospital visits, familiar faces, waiting rooms, and days when she has to leave her normal routine behind.

Her family understands much more.

They know that blood transfusions are essential for keeping her healthy and helping her body receive the red blood cells it needs. They also know she becomes lethargic when she needs another transfusion and that regular transfusions come with their own challenges.

One of the major problems is iron overload. With repeated transfusions, extra iron can gradually build up in the body. Unlike many substances, the body has no natural way to remove large amounts of this excess iron. Over time, it can damage important organs. That is why children like Mehak may also need iron-chelation medicines to reduce the amount of iron stored in their bodies.

There are other worries too. Even with careful screening and safe transfusion practices, repeated blood transfusions can carry risks, including infections and transfusion-related complications. Families therefore live with two realities at the same time: the blood is necessary, and the treatment itself requires careful monitoring.

For Mehak’s family, treatment is not limited to the hospital bed.

It means arranging transport, taking time away from work and other responsibilities, finding blood when it is needed, paying for medicines and travel, and planning life around hospital appointments. For families who live far from a specialized treatment center, the journey can be even harder. A transfusion that may take only a few hours can require an entire day, or sometimes much more, because of the distance they have to travel.

And then there is the emotional side that is harder to measure.

A parent watches a small child receive treatment and learns to become comfortable with things no parent should have to explain so early in life. They learn about blood counts, transfusion schedules, medicines, iron levels, and possible complications. They learn to notice small changes in their child. They become careful planners because missing treatment is not simply missing an appointment.

Yet Mehak is still Mehak.

She is not only her disease. She is a little girl growing up around all of this. She has moments of happiness, curiosity, playfulness, and laughter. Her treatment is a part of her life, but it does not define her whole life.

Thalassemia is a chronic inherited blood disorder that remains a significant health problem in many parts of the world. For children with thalassemia major, regular treatment can continue for many years. How well a child does depends on many factors, including access to safe blood, appropriate medicines, monitoring, management of complications, the child's response to treatment, and the ability of the family to maintain long-term care.

Prevention is also an important part of the story.

Because thalassemia is inherited, carrier screening and genetic counseling can help couples understand their risk before having children. Knowing whether both partners carry a thalassemia gene can allow families to make informed reproductive decisions.

For families like Mehak’s, however, prevention is a conversation for another time.

Right now, there is a little girl who needs her next transfusion.

And there is a family that will once again pack a bag, make the journey to the hospital, sit beside her, and wait.

For Mehak, this has become part of growing up.

For her family, it is simply what they do because they love her.

Note: Patient name has been changed to protect privacy. 

Warriors and Survivors - 281

Children Cancer Stories by Rukh Yusuf - Blog # 281

I am Rukh Yusuf, Clinical Pharmacist, also specialized in Total Parenteral Nutrition and Bone Marrow Transplant. I have worked in the Pediatric Oncology unit of a public hospital. The mission of this blog is to bring to you the real-life stories of child patients suffering from cancer. Cancer is still a difficult disease to handle and treat. However, when it strikes the children, some so young that they cannot even speak, their agony is beyond expression and words. Let us pray especially for children suffering from cancer for early and complete remission. May Allah shower His Merciful Blessings upon them. Aameen. 

A Six Year Old's Courage: Ahad's Journey Through Leukemia

The Day Everything Changed: Ahad was always full of energy. At six years old, he was the kind of child who couldn't sit still always running, always playing, always asking questions about the world around him. His mother, Fatima, remembers those days with a bittersweet smile. She remembers his infectious laugh echoing through their modest home in Lahore. She remembers him insisting on helping her cook, standing on his tiptoes to reach the kitchen counter. She remembers thinking life was exactly as it should be.

Then came the fevers: It started subtly. A fever here and there, nothing alarming by itself. Ahad's parents, like most parents, attributed it to seasonal illness. They gave him over-the-counter medication and waited for it to pass. But the fevers kept returning, more frequently each time. What concerned Fatima more was the unusual tiredness. Her energetic little boy, who once played for hours, now needed to rest after just a few minutes of play.

"I knew something was wrong," Fatima recalls quietly. "A mother knows her child. I could feel it in my heart before my mind could name it."

The Diagnosis That Stopped Time:  The journey to diagnosis wasn't straightforward. Their local doctor initially suspected a prolonged viral infection. When antibiotics didn't help and the fevers persisted, they visited a specialist. More tests were ordered. More waiting. More uncertainty.

When the word "leukemia" was finally spoken in a quiet hospital room, Fatima felt as though the ground beneath her had disappeared. Ahad's father, Hassan, sat motionless, unable to process what the doctor was saying. Leukemia! childhood cancer, was something that happened to other families, not theirs. Not to their perfect, joyful little boy.

The diagnosis was acute lymphoblastic leukemia (ALL). It meant that Ahad's bone marrow was producing abnormal white blood cells at an alarming rate, crowding out healthy cells and weakening his immune system. It meant chemotherapy. It meant months, possibly years of treatment. It meant their lives would never be the same.

The Reality of Treatment: Ahad's treatment began just days after diagnosis. The first round of chemotherapy was brutal in ways the family hadn't anticipated. The side effects, nausea, hair loss, mouth sores, extreme fatigue transformed their little boy into someone they barely recognized. Yet somehow, Ahad adapted with a resilience that humbled his parents.

"He never complained," Fatima says, her voice catching slightly. "When his hair fell out in clumps, he would ask, 'Mama, will it grow back?' When the medication made him sick, he would say, 'It's okay, Mama. The medicine is fighting the bad cells.' A six-year-old shouldn't have to be this brave."

The Unseen Battles:  While Ahad fought his physical battle against leukemia, his family fought their own invisible wars. The financial burden was crushing. Each hospital visit, each round of chemotherapy, each medication drained their modest savings. Hassan, a shopkeeper, had to reduce his work hours to accompany Ahad to Lahore's tertiary care hospital, an hour away from their home. The loss of income created stress that rippled through everything.

Fatima abandoned her small tailoring business. She needed to be with Ahad full-time managing his medications, monitoring his symptoms, providing the emotional support a frightened child requires. The emotional toll was equally devastating. Watching your child suffer, feeling helpless despite doing everything right, carrying the constant fear of relapse these are weights no parent should bear. The stigma was another burden. Some in their community avoided them, as if childhood cancer was somehow contagious. Relatives who once visited frequently became distant. Ahad noticed the whispers, the worried glances.

A Light in the Darkness: Yet within this darkness, there are moments of light. Ahad's oncology team at the hospital has become like family doctors and nurses who celebrate his small victories with genuine joy. A complete blood count that looks better than last month. A week without fever. The ability to play for an hour without exhaustion. Now, eighteen months into treatment, Ahad is in remission. He's still undergoing maintenance chemotherapy a gentler phase designed to prevent relapse but he's healing. His hair is growing back, curly and thick. His energy is returning. He's returned to school part-time, and his teacher says he's the bravest student she's ever known.

Ahad's story is one of millions. Pediatric cancer affects thousands of children in Pakistan annually, yet awareness remains tragically low. Many families, like Ahad's, discover their child's illness only when it's advanced. Better screening, earlier detection, improved access to treatment, and financial support could change these stories.

As you read this, somewhere in Pakistan, another mother is watching her child endure chemotherapy. Another family is struggling with impossible choices. They need not just our sympathy, but our action, our advocacy, our support, our commitment to ensuring that every child, regardless of where they're born, has access to hope and healing.

Ahad's journey continues. And with every day he fights, he reminds us all why pediatric oncology awareness matters.

Note: Patient name has been changed to protect privacy.